MassMutual Private Wealth & Trust’s Madrigal Pharmaceuticals MDGL Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.04K	Sell	10 -1	-9%	-$528	﹤0.01%	1613
2026 Q2	$5.91K	Buy	11 +1	+10%	+$512	﹤0.01%	1612
2026 Q1	$5.24K	Hold	10	–	–	﹤0.01%	1654
2025 Q4	$5.82K	Hold	10	–	–	﹤0.01%	1616
2025 Q3	$4.59K	Hold	10	–	–	﹤0.01%	1707
2025 Q2	$3.03K	Sell	10 -12	-55%	-$3.58K	﹤0.01%	1817
2025 Q1	$7.29K	Buy	22 +12	+120%	+$3.94K	﹤0.01%	1424
2024 Q4	$3.09K	Buy	10 +4	+67%	+$1.12K	﹤0.01%	1698
2024 Q3	$1.27K	Sell	6 -11	-65%	-$2.81K	﹤0.01%	1789
2024 Q2	$4.76K	Buy	+17	New	+$4.05K	﹤0.01%	1336
2023 Q4	–	Sell	-2	Closed	-$292	–	2032
2023 Q3	$292	Buy	2 +1	+100%	+$188	﹤0.01%	1895
2023 Q2	$231	Buy	+1	New	+$271	﹤0.01%	1864
2022 Q1	–	Sell	-7	Closed	-$1K	–	1588
2021 Q4	$1K	Buy	+7	New	+$575	﹤0.01%	1256

Other funds holding MDGL

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

MassMutual Private Wealth & Trust's MDGL Position: Q3 2026 in Review

MassMutual Private Wealth & Trust reduced its Madrigal Pharmaceuticals (MDGL) stake by 9.1% in Q3 2026, selling an estimated $528 and leaving 10 shares worth $5.04K. The position accounts for ﹤0.01% of the portfolio, ranked #1613.

MassMutual Private Wealth & Trust first reported a position in MDGL in Q4 2021 and has held it in 13 quarters since. The position peaked at $7.29K in Q1 2025. 235 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

MassMutual Private Wealth & Trust held 10 shares of Madrigal Pharmaceuticals worth $5.04K as of Q3 2026.
MassMutual Private Wealth & Trust sold 1 Madrigal Pharmaceuticals share in Q3 2026, an estimated $528.
Madrigal Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1613 holding.
MassMutual Private Wealth & Trust first reported a position in Madrigal Pharmaceuticals in Q4 2021 and has held it in 13 quarters since.
MassMutual Private Wealth & Trust's Madrigal Pharmaceuticals position peaked at $7.29K in Q1 2025.
235 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.